Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
CSL Rh(D) IMMUNOGLOBULIN VF (human) 250 IU injection vial, CSL Behring Australia Pty Ltd, CON-1341
Product name
CSL Rh(D) IMMUNOGLOBULIN VF (human) 250 IU injection vial
Sponsor name
CSL Behring Australia Pty Ltd
Consent start
Consent no.
CON-1341
Duration
The consent is effective from 21 March 2025 until 1 October 2031.
Standard
Part 2 Subsection 10(9) Schedule 1 Item 12 of Therapeutic Goods (Standard for Human Cell and Tissue Products - Donor Selection Requirements) (TGO 108) Order 2021
Non-compliance with standard
The products can now be manufactured from plasma from blood donors that do not
meet the requirement of a 3-month period of ineligibility from the date the
person last engaged in the sexual activity of a nature that puts the person at
an increased risk of acquiring infectious diseases that could be transmitted
through blood, cells or tissues.
Import, Supply, &/or Export
supply
Therapeutic product type
Blood, tissues, and biologicals